Soluble suppression of tumorigenicity-2 (sST2) predicts mortality and right heart failure in LVAD patients https://www.medrxiv.org/content/10.1101/2023.02.06.23285564
Soluble suppression of tumorigenicity-2 (sST2) predicts mortality and right heart failure in LVAD patients https://www.medrxiv.org/content/10.1101/2023.02.06.23285564